These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Mice Lacking GPR88 Show Motor Deficit, Improved Spatial Learning, and Low Anxiety Reversed by Delta Opioid Antagonist. Meirsman AC; Le Merrer J; Pellissier LP; Diaz J; Clesse D; Kieffer BL; Becker JA Biol Psychiatry; 2016 Jun; 79(11):917-27. PubMed ID: 26188600 [TBL] [Abstract][Full Text] [Related]
6. The orphan GPCR, GPR88, modulates function of the striatal dopamine system: a possible therapeutic target for psychiatric disorders? Logue SF; Grauer SM; Paulsen J; Graf R; Taylor N; Sung MA; Zhang L; Hughes Z; Pulito VL; Liu F; Rosenzweig-Lipson S; Brandon NJ; Marquis KL; Bates B; Pausch M Mol Cell Neurosci; 2009 Dec; 42(4):438-47. PubMed ID: 19796684 [TBL] [Abstract][Full Text] [Related]
7. Genetic deletion of GPR88 enhances the locomotor response to L-DOPA in experimental parkinsonism while counteracting the induction of dyskinesia. Mantas I; Yang Y; Mannoury-la-Cour C; Millan MJ; Zhang X; Svenningsson P Neuropharmacology; 2020 Jan; 162():107829. PubMed ID: 31666199 [TBL] [Abstract][Full Text] [Related]
8. Striatal GPR88 expression is confined to the whole projection neuron population and is regulated by dopaminergic and glutamatergic afferents. Massart R; Guilloux JP; Mignon V; Sokoloff P; Diaz J Eur J Neurosci; 2009 Aug; 30(3):397-414. PubMed ID: 19656174 [TBL] [Abstract][Full Text] [Related]
9. G-protein coupled receptor 88 knockdown in the associative striatum reduces psychiatric symptoms in a translational male rat model of Parkinson disease. Galet B; Ingallinesi M; Pegon J; Do Thi A; Ravassard P; Faucon Biguet N; Meloni R J Psychiatry Neurosci; 2021 Jan; 46(1):E44-E55. PubMed ID: 32667145 [TBL] [Abstract][Full Text] [Related]
11. Loss of glutamic acid decarboxylase (Gad67) in striatal neurons expressing the Drdr1a dopamine receptor prevents L-DOPA-induced dyskinesia in 6-hydroxydopamine-lesioned mice. Zhang K; Chammas C; Soghomonian JJ Neuroscience; 2015 Sep; 303():586-94. PubMed ID: 26188284 [TBL] [Abstract][Full Text] [Related]
12. GPR88 in A Meirsman AC; de Kerchove d'Exaerde A; Kieffer BL; Ouagazzal AM Eur J Neurosci; 2017 Aug; 46(4):2026-2034. PubMed ID: 28700108 [TBL] [Abstract][Full Text] [Related]
13. Striatal dopamine D2 receptors regulate effort but not value-based decision making and alter the dopaminergic encoding of cost. Filla I; Bailey MR; Schipani E; Winiger V; Mezias C; Balsam PD; Simpson EH Neuropsychopharmacology; 2018 Oct; 43(11):2180-2189. PubMed ID: 30082890 [TBL] [Abstract][Full Text] [Related]
14. GPR88 in D1R-Type and D2R-Type Medium Spiny Neurons Differentially Regulates Affective and Motor Behavior. Meirsman AC; Ben Hamida S; Clarke E; de Kerchove d'Exaerde A; Darcq E; Kieffer BL eNeuro; 2019; 6(4):. PubMed ID: 31346000 [TBL] [Abstract][Full Text] [Related]
15. Mapping GPR88-Venus illuminates a novel role for GPR88 in sensory processing. Ehrlich AT; Semache M; Bailly J; Wojcik S; Arefin TM; Colley C; Le Gouill C; Gross F; Lukasheva V; Hogue M; Darcq E; Harsan LA; Bouvier M; Kieffer BL Brain Struct Funct; 2018 Apr; 223(3):1275-1296. PubMed ID: 29110094 [TBL] [Abstract][Full Text] [Related]
16. The orphan receptor GPR88 blunts the signaling of opioid receptors and multiple striatal GPCRs. Laboute T; Gandía J; Pellissier LP; Corde Y; Rebeillard F; Gallo M; Gauthier C; Léauté A; Diaz J; Poupon A; Kieffer BL; Le Merrer J; Becker JA Elife; 2020 Jan; 9():. PubMed ID: 32003745 [TBL] [Abstract][Full Text] [Related]
17. Knock-Down of GPR88 in the Dorsal Striatum Alters the Response of Medium Spiny Neurons to the Loss of Dopamine Input and L-3-4-Dyhydroxyphenylalanine. Ingallinesi M; Galet B; Pegon J; Faucon Biguet N; Do Thi A; Millan MJ; Mannoury la Cour C; Meloni R Front Pharmacol; 2019; 10():1233. PubMed ID: 31708775 [TBL] [Abstract][Full Text] [Related]
18. Compromised Dopaminergic Encoding of Reward Accompanying Suppressed Willingness to Overcome High Effort Costs Is a Prominent Prodromal Characteristic of the Q175 Mouse Model of Huntington's Disease. Covey DP; Dantrassy HM; Zlebnik NE; Gildish I; Cheer JF J Neurosci; 2016 May; 36(18):4993-5002. PubMed ID: 27147652 [TBL] [Abstract][Full Text] [Related]
19. The dopamine depleting agent tetrabenazine alters effort-related decision making as assessed by mouse touchscreen procedures. Yang JH; Presby RE; Rotolo RA; Quiles T; Okifo K; Zorda E; Fitch RH; Correa M; Salamone JD Psychopharmacology (Berl); 2020 Sep; 237(9):2845-2854. PubMed ID: 32561947 [TBL] [Abstract][Full Text] [Related]
20. Developmental and adult expression patterns of the G-protein-coupled receptor GPR88 in the rat: Establishment of a dual nuclear-cytoplasmic localization. Massart R; Mignon V; Stanic J; Munoz-Tello P; Becker JA; Kieffer BL; Darmon M; Sokoloff P; Diaz J J Comp Neurol; 2016 Oct; 524(14):2776-802. PubMed ID: 26918661 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]